Last update 01 Nov 2024

Techdow Pharma Netherlands BV

Subsidiary Company|
Netherlands

Overview

Basic Info

Introduction
Founded in 2004, Techdow Pharma Netherlands BV, a subsidiary of Shenzhen Hepalink Pharmaceutical, is a premier Chinese exporter of enoxaparin sodium APIs and low molecular weight heparin products. Techdow made history as its enoxaparin sodium injection became the first biosimilar endorsed by the EMA.

Tags

Nervous System Diseases
Respiratory Diseases
Cardiovascular Diseases
Chemical drugs

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Disease DomainCount
Nervous System Diseases1
Top 5 Drug TypeCount
Chemical drugs1
Top 5 TargetCount
AT III(Antithrombin-III)1

Related

1
Drugs associated with Techdow Pharma Netherlands BV
Enoxaparin Sodium
Target
AT III
Mechanism
AT III activators
Active Org.
Sanofi-Aventis Australia Pty Ltd. [+8]
Originator Org.
SanofiSanofi
Active Indication
Pulmonary Embolism [+7]
Inactive Indication
Abdominal Neoplasms [+11]
Drug Highest PhaseApproved
First Approval Ctry. / Loc.
AU
First Approval Date12 Feb 1993
100 Clinical Results associated with Techdow Pharma Netherlands BV
Login to view more data
0 Patents (Medical) associated with Techdow Pharma Netherlands BV
Login to view more data
100 Deals associated with Techdow Pharma Netherlands BV
Login to view more data
100 Translational Medicine associated with Techdow Pharma Netherlands BV
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 22 Nov 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Approved
1
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
Enoxaparin Sodium
 ( AT III )		Venous Thrombosis
More
Approved
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free